Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes
- PMID: 24457369
- DOI: 10.1136/bjophthalmol-2013-304019
Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes
Abstract
Background: Since there is evidence that the Fc domain of antivascular endothelial growth factor drugs may cause unexpected consequences in retinal and choroidal vessels, the effects of intravitreal ranibizumab and aflibercept on monkey eyes were investigated.
Methods: Four cynomolgus monkeys were intravitreally injected with 0.5 mg of ranibizumab and another four with 2 mg of aflibercept. Two untreated monkeys served as controls. Funduscopy, fluorescein angiography (FA), spectral-domain-optical coherence tomography (SD-OCT) and measurement of intraocular pressure (IOP) were performed. The eyes were inspected by light, fluorescence and electron microscopy. The diameter of the choriocapillaris (CC) was measured by morphometry, and the areas of the CC with free haemoglobin, CC fenestrations and endothelial thickness were quantified.
Results: Analysis showed ranibizumab permeated the retina via intercellular clefts, whereas aflibercept was taken up by ganglion cells, cells of the inner and outer retinal layers and the retinal pigment epithelium (RPE). Stasis and haemolysis in the choriocapillaris and choroidal vessels were more frequent after aflibercept treatment, which caused hypertrophy and death of individual RPE cells. The area of the CC was significantly reduced after both drugs compared with controls, but the reduction of the CC endothelium thickness, number of fenestrations and the areas with haemolysis were more pronounced after aflibercept.
Conclusions: Ranibizumab permeated the retina through intercellular spaces, whereas aflibercept was taken up by neuronal and RPE cells. Aflibercept induced protein complex formation and more haemolysis in the choriocapillaris, leading to individual RPE cell death. The clinical significance and relation of these findings to the Fc domain or to other characteristics of aflibercept remain to be investigated.
Keywords: Choroid; Drugs; Neovascularisation; Retina.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Similar articles
-
The effects of VEGF-A-inhibitors aflibercept and ranibizumab on the ciliary body and iris of monkeys.Graefes Arch Clin Exp Ophthalmol. 2016 Jun;254(6):1117-25. doi: 10.1007/s00417-016-3344-8. Epub 2016 Apr 22. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 27106625
-
Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes.Expert Opin Biol Ther. 2013 Feb;13(2):157-67. doi: 10.1517/14712598.2012.748741. Epub 2012 Nov 29. Expert Opin Biol Ther. 2013. PMID: 23190450
-
Effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys.PLoS One. 2014 Nov 21;9(11):e113701. doi: 10.1371/journal.pone.0113701. eCollection 2014. PLoS One. 2014. PMID: 25415380 Free PMC article.
-
[Basic in vitro studies on VEGF inhibition with aflibercept: similarities and differences to other VEGF-binding therapeutic proteins].Klin Monbl Augenheilkd. 2015 Mar;232(3):295-302. doi: 10.1055/s-0034-1383142. Epub 2014 Nov 13. Klin Monbl Augenheilkd. 2015. PMID: 25393440 Review. German.
-
Development of the human choriocapillaris.Eye (Lond). 2010 Mar;24(3):408-15. doi: 10.1038/eye.2009.318. Epub 2010 Jan 15. Eye (Lond). 2010. PMID: 20075975 Free PMC article. Review.
Cited by
-
Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis.Ophthalmic Epidemiol. 2016;23(2):71-9. doi: 10.3109/09286586.2015.1090004. Epub 2016 Feb 8. Ophthalmic Epidemiol. 2016. PMID: 26855278 Free PMC article.
-
Comment on: Impact of switching from ranibizumab to aflibercept on the number of intravitreous injection and follow up visit in wet AMD: results of real-life ELU study.Int J Ophthalmol. 2021 Jul 18;14(7):1127-1128. doi: 10.18240/ijo.2021.07.26. eCollection 2021. Int J Ophthalmol. 2021. PMID: 34282403 Free PMC article. No abstract available.
-
Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy.Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):233-235. doi: 10.1007/s00417-017-3797-4. Epub 2017 Sep 6. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 28879555 No abstract available.
-
Asymmetric response to ranibizumab in mixed choroidal neovascularization in a neovascular age-related macular degeneration diagnosed on OCT angiography - case report.BMC Ophthalmol. 2021 Jan 15;21(1):42. doi: 10.1186/s12886-021-01810-z. BMC Ophthalmol. 2021. PMID: 33451290 Free PMC article.
-
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion.Graefes Arch Clin Exp Ophthalmol. 2024 Dec;262(12):3837-3845. doi: 10.1007/s00417-024-06562-2. Epub 2024 Jul 22. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 39037469 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources